Voloridge Investment Management, LLC Aurinia Pharmaceuticals Inc. Transaction History

Voloridge Investment Management, LLC

  • $26.2 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$10.05 - $22.48 $8.85 Million - $19.8 Million
-880,583 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$17.78 - $33.08 $4.51 Million - $8.4 Million
253,829 Added 40.5%
880,583 $20.1 Million
Q3 2021

Nov 15, 2021
BUY
$10.93 - $23.55 $6.85 Million - $14.8 Million
626,754 New
626,754 $13.9 Million
Q1 2020

May 15, 2020
SELL
$11.34 - $21.46 $241,791 - $457,570
-21,322 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$3.88 - $21.42 $82,729 - $456,717
21,322 New
21,322 $432,000

Others Institutions Holding AUPH

# of Institutions
210
Shares Held
58.2M
Call Options Held
1.14M
Put Options Held
1.51M
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.1B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email